Evidence map›Paper›PMID 33710379›Full record

ReviewArchives of microbiology2021

Recent advances in the bioprospection and applications of chitinolytic bacteria for valorization of waste chitin.

Neeraja P Dhole, Mudasir A Dar, Radhakrishna S Pandit

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. An Overview of Chitinase Zymography: Past and Present Methods and Protocols.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Neeraja P DholeDepartment of Zoology, Savitribai Phule Pune University, Ganeshkhind, Pune, 411007, Maharashtra, India.
Mudasir A DarSchool of the Environment and Safety Engineering, Jiangsu University, Zhenjiang, 212013, People's Republic of China. mudasir.dar@unipune.ac.in.
Radhakrishna S PanditDepartment of Zoology, Savitribai Phule Pune University, Ganeshkhind, Pune, 411007, Maharashtra, India. rspandit@unipune.ac.in.ORCID http://orcid.org/0000-0003-0918-8284

Funding

Council of Scientific and Industrial Research, India 09/137(0615)/2019-EMR-1
6 · The paper itself

Abstract

One of the most abundant natural polymers on earth, chitin is a fibrous and structural polysaccharide, composed of N-acetyl-D-glucosamine. The biopolymer is the major structural constituent of fungi, arthropods, mollusks, nematodes, and some algae. The biodegradation of chitin is largely manifested by chitinolytic enzyme secreting organisms including bacteria, insects, and plants. Among them, bacterial chitinases represent the most promising, inexpensive, and sustainable source of proteins that can be employed for industrial-scale applications. To this end, the presented review comes at a timely moment to highlight the major sources of chitinolytic bacteria. It also discusses the potential pros and cons of prospecting bacterial chitinases that can be easily manipulated through genetic engineering. Additionally, we have elaborated the recent applications of the chitin thereby branding chitinases as potential candidates for biorefinery and biomedical research for eco-friendly and sustainable management of chitin waste in the environment.

Indexed as

BioprospectingAcetylglucosamineBacteriaBacterial ProteinsBiodegradation, EnvironmentalChitinChitinasesGenetic EngineeringAcetylglucosamineBacterial ProteinsChitinChitinasesBiomedical applicationsBioprospectionChitinChitinasesChitinolytic bacteriaN-Acetyl-D-glucosamine

Identifiers

PMID33710379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.